Minimizing SARS-CoV-2 exposure when performing surgical interventions during the COVID-19 pandemic.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 11 04 2020
revised: 28 04 2020
accepted: 29 04 2020
pubmed: 22 5 2020
medline: 24 6 2020
entrez: 22 5 2020
Statut: ppublish

Résumé

Infection from the SARS-CoV-2 virus has led to the COVID-19 pandemic. Given the large number of patients affected, healthcare personnel and facility resources are stretched to the limit; however, the need for urgent and emergent neurosurgical care continues. This article describes best practices when performing neurosurgical procedures on patients with COVID-19 based on multi-institutional experiences. We assembled neurosurgical practitioners from 13 different health systems from across the USA, including those in hot spots, to describe their practices in managing neurosurgical emergencies within the COVID-19 environment. Patients presenting with neurosurgical emergencies should be considered as persons under investigation (PUI) and thus maximal personal protective equipment (PPE) should be donned during interaction and transfer. Intubations and extubations should be done with only anesthesia staff donning maximal PPE in a negative pressure environment. Operating room (OR) staff should enter the room once the air has been cleared of particulate matter. Certain OR suites should be designated as covid ORs, thus allowing for all neurosurgical cases on covid/PUI patients to be performed in these rooms, which will require a terminal clean post procedure. Each COVID OR suite should be attached to an anteroom which is a negative pressure room with a HEPA filter, thus allowing for donning and doffing of PPE without risking contamination of clean areas. Based on a multi-institutional collaborative effort, we describe best practices when providing neurosurgical treatment for patients with COVID-19 in order to optimize clinical care and minimize the exposure of patients and staff.

Sections du résumé

BACKGROUND BACKGROUND
Infection from the SARS-CoV-2 virus has led to the COVID-19 pandemic. Given the large number of patients affected, healthcare personnel and facility resources are stretched to the limit; however, the need for urgent and emergent neurosurgical care continues. This article describes best practices when performing neurosurgical procedures on patients with COVID-19 based on multi-institutional experiences.
METHODS METHODS
We assembled neurosurgical practitioners from 13 different health systems from across the USA, including those in hot spots, to describe their practices in managing neurosurgical emergencies within the COVID-19 environment.
RESULTS RESULTS
Patients presenting with neurosurgical emergencies should be considered as persons under investigation (PUI) and thus maximal personal protective equipment (PPE) should be donned during interaction and transfer. Intubations and extubations should be done with only anesthesia staff donning maximal PPE in a negative pressure environment. Operating room (OR) staff should enter the room once the air has been cleared of particulate matter. Certain OR suites should be designated as covid ORs, thus allowing for all neurosurgical cases on covid/PUI patients to be performed in these rooms, which will require a terminal clean post procedure. Each COVID OR suite should be attached to an anteroom which is a negative pressure room with a HEPA filter, thus allowing for donning and doffing of PPE without risking contamination of clean areas.
CONCLUSION CONCLUSIONS
Based on a multi-institutional collaborative effort, we describe best practices when providing neurosurgical treatment for patients with COVID-19 in order to optimize clinical care and minimize the exposure of patients and staff.

Identifiants

pubmed: 32434798
pii: neurintsurg-2020-016161
doi: 10.1136/neurintsurg-2020-016161
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

643-647

Investigateurs

Mark Bain (M)
Bernard Bendock (B)
Alan S Boulos (AS)
Webster Crowley (W)
Richard Fessler (R)
Andrew Grande (A)
Lee Guterman (L)
Ricardo Hanel (R)
L Daniel Hoit (L)
Nelson Hopkins (N)
Jay Howington (J)
Robert James (R)
Brian Jankowitz (B)
Alex A Khalessi (AA)
Giuseppe Lanzino (G)
Demetrius Lopes (D)
William Mack (W)
Robert Mericle (R)
Chris Ogilvy (C)
Robert Replogle (R)
Rafael Rodriguez (R)
Eric Saugaveau (E)
Alex Spiotta (A)
Ali Sultan (A)
Rabih Tawk (R)
Ajith Thomas (A)
Raymond Turner (R)
Babu Welch (B)
Jonathan White (J)

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: There are no competing interests for any author.

Auteurs

Aditya S Pandey (AS)

Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA adityap@med.umich.edu.

Andrew J Ringer (AJ)

Neurosurgery, Mayfield Clinic, University of Cincinnati, Cincinnati, Ohio, USA.

Ansaar T Rai (AT)

Interventional Neuroradiology, West Virginia University Hospital, Morgantown, West Virginia, USA.

Peter Kan (P)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

Pascal Jabbour (P)

Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Adnan H Siddiqui (AH)

Neurosurgery, University at Buffalo, Buffalo, New York, USA.

Elad I Levy (EI)

Neurosurgery and Radiology and Canon Stroke and Vascular Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Neurosurgery, Gates Vascular Institute at Kaleida Health, Buffalo, New York, USA.

Kenneth V Snyder (KV)

Neurosurgery, Gates Vascular Institute at Kaleida Health, Buffalo, New York, USA.
Neurosurgery and Neurology and Canon Stroke and Vascular Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.

Howard Riina (H)

Department of Neurosurgery, New York University - Langone Medical Center, New York, New York, USA.

Omar Tanweer (O)

Department of Neurosurgery, New York University - Langone Medical Center, New York, New York, USA.

Michael R Levitt (MR)

Neurological Surgery, Radiology and Mechanical Engineering, University of Washington, Seattle, Washington, USA.

Louis J Kim (LJ)

Department of Neurological Surgery, University of Washington, Seattle, Washington, USA.

Erol Veznedaroglu (E)

Drexel Neuroscience Institute and GNI, Philadelphia, Pennsylvania, USA.

Mandy J Binning (MJ)

Drexel Neurosciences Institute, Philadelphia, Pennsylvania, USA.

Adam S Arthur (AS)

Semmes-Murphey Neurologic and Spine Institute, Memphis, Tennessee, USA.
Neurosurgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

J Mocco (J)

The Mount Sinai Health System, New York, New York, USA.

Clemens Schirmer (C)

Department of Neurosurgery and Neuroscience Institute, Geisinger Health System and Geisinger Commonwealth School of Medicine, Wilkes-Barre, PA, USA.
Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria.

Byron Gregory Thompson (BG)

Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA.

David Langer (D)

Neurosurgery, Lenox Hill Hospital, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH